CG
WST icon

Caprock Group’s West Pharmaceutical WST Stock Holding History

Caprock Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,078
Closed -$1.4M – 1313
2025
Q4 		$1.4M Sell
5,078
-887
-15% -$243K 0.03% 500
2025
Q3 		$1.47M Buy
+5,965
New +$1.45M 0.04% 438
2024
Q4 		– Sell
-901
Closed -$270K – 1055
2024
Q3 		$270K Sell
901
-204
-18% -$62.5K 0.01% 756
2024
Q2 		$364K Buy
1,105
+68
+7% +$24K 0.01% 627
2024
Q1 		$410K Sell
1,037
-10
-1% -$3.7K 0.02% 469
2023
Q4 		$369K Sell
1,047
-79
-7% -$28K 0.02% 478
2023
Q3 		$422K Sell
1,126
-61
-5% -$23.6K 0.03% 400
2023
Q2 		$454K Buy
1,187
+147
+14% +$52.5K 0.03% 397
2023
Q1 		$360K Buy
+1,040
New +$304K 0.03% 442
2022
Q3 		– Sell
-773
Closed -$234K – 609
2022
Q2 		$234K Buy
773
+78
+11% +$25.4K 0.02% 457
2022
Q1 		$285K Buy
695
+113
+19% +$44.2K 0.03% 443
2021
Q4 		$273K Buy
+582
New +$251K 0.02% 462

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caprock Group's WST Position: Q1 2026 in Review

Caprock Group sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 5,078 shares — an estimated $1.4M sold.

Caprock Group first reported a position in WST in Q4 2021 and held it in 12 quarters. The position peaked at $1.47M in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Caprock Group reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Caprock Group sold 5,078 West Pharmaceutical shares in Q1 2026, an estimated $1.4M.
  • Caprock Group first reported a position in West Pharmaceutical in Q4 2021 and held it in 12 quarters.
  • Caprock Group's West Pharmaceutical position peaked at $1.47M in Q3 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.